PHK
ACOR

Point72 Hong Kong’s Acorda Therapeutics ACOR Stock Holding History

Point72 Hong Kong’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-11
Closed -$10K – 1441
2019
Q2 		$10K Buy
11
+3
+38% +$3.69K ﹤0.01% 862
2019
Q1 		$12K Sell
8
-1
-11% -$1.8K ﹤0.01% 746
2018
Q4 		$18K Buy
9
+8
+800% +$17.4K 0.01% 468
2018
Q3 		$3K Buy
+1
New +$3.1K ﹤0.01% 755
2018
Q2 		– Hold
0
– – – 849
2017
Q2 		– Hold
0
– – – 1077
2017
Q1 		– Sell
-6
Closed -$17.3K – 1069
2016
Q4 		$13K Buy
6
+2
+50% +$4.75K 0.01% 618
2016
Q3 		$10K Buy
+4
New +$11.9K 0.01% 650

Other funds holding ACOR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Hong Kong's ACOR Position: Q3 2019 in Review

Point72 Hong Kong sold out of Acorda Therapeutics (ACOR) in Q3 2019, closing a stake of 11 shares — an estimated $10K sold.

Point72 Hong Kong first reported a position in ACOR in Q3 2016 and held it in 6 quarters. The position peaked at $18K in Q4 2018. 151 funds tracked by Wall St. Rank hold ACOR as of Q3 2019.

  • Point72 Hong Kong reported no remaining Acorda Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Point72 Hong Kong sold 11 Acorda Therapeutics shares in Q3 2019, an estimated $10K.
  • Point72 Hong Kong first reported a position in Acorda Therapeutics in Q3 2016 and held it in 6 quarters.
  • Point72 Hong Kong's Acorda Therapeutics position peaked at $18K in Q4 2018.
  • 151 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q3 2019.

Based on Point72 Hong Kong's 13F filing for Q3 2019, filed 14 Nov 2019.